Other studies show that TRPM7 has potential to be a biomarker in pre-malignant states, as it has been shown to be overexpressed in early stages of various cancers and also shown to contain genetic mutations/polymorphisms in cancers [16]. This evidence concerns the gene TRPM7 and cancer.